首页> 外文OA文献 >PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma

【2h】

PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma

机译：PUB062 EGFR-TKIS治疗过程中脑转移的危险因素，用于EGFR-突变的晚期肺癌患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hui Zhu; Xiaoyan Ma; Jinming Yu;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma [J] . Hui Zhu, Xiaoyan Ma, Jinming Yu Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB062 EGFR-TKIS治疗过程中脑转移的危险因素，用于EGFR-突变的晚期肺癌患者
2. PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma [J] . Hui Zhu, Xiaoyan Ma, Jinming Yu Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB062 EGFR-TKIS治疗过程中脑转移的危险因素，用于EGFR-突变的晚期肺癌患者
3. Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer [J] . Wen Ouyang, Jing Yu, Yan Zhou, BMC Cancer . 2020,第1期

机译：EGFR-突变晚期非小细胞肺癌患者中叉脑转移的危险因素
4. The Link of Interferon Regulatory Factors 4 and 7 on the Patient’s Survival in Lung Adenocarcinoma [C] . Altan Kara, Ali Aydin, Ahsen Morva, International Conference on Cancer Care Informatics . 2018

机译：干扰素调节因子4和7与肺腺癌患者生存的关系
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma [O] . Xiaoyan Ma, Hui Zhu, Hongbo Guo, 2016

机译：EGFR突变的晚期肺腺癌患者EGFR-TKIs治疗过程中脑转移的危险因素
7. Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis [O] . Yanxin Chen, Jianping Wei, Jing Cai, 2019

机译：脑放射治疗和EGFR-TKI的组合治疗比单独的TKIS更有效，因为EGFR-突变体肺腺癌患者无症状脑转移

PUB062 Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅